Details of the Drug Reposition

General Information of This Drug (ID: DMW1NKO)

Drug Name
X-82   DMW1NKO

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Age-related macular degeneration DIS0XS2C 9B75.0 Phase 2 [1]
------------------------------------------------------------------------------------
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 1 [2]
Macular degeneration DISLKKHD 9B78.3 Phase 1 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02348359) X-82 to Treat Age-related Macular Degeneration. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Tyrogenex.